Ensign Peak Advisors’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-16,150
| Closed | -$20.2K | – | 1736 |
|
2023
Q4 | $20.2K | Hold |
16,150
| – | – | ﹤0.01% | 1735 |
|
2023
Q3 | $21K | Hold |
16,150
| – | – | ﹤0.01% | 1752 |
|
2023
Q2 | $27.8K | Hold |
16,150
| – | – | ﹤0.01% | 1757 |
|
2023
Q1 | $23.6K | Sell |
16,150
-325,653
| -95% | -$475K | ﹤0.01% | 1768 |
|
2022
Q4 | $554K | Sell |
341,803
-63,172
| -16% | -$102K | ﹤0.01% | 1591 |
|
2022
Q3 | $1.36M | Hold |
404,975
| – | – | ﹤0.01% | 930 |
|
2022
Q2 | $1.47M | Sell |
404,975
-35,714
| -8% | -$130K | ﹤0.01% | 940 |
|
2022
Q1 | $3.19M | Sell |
440,689
-19,462
| -4% | -$141K | 0.01% | 711 |
|
2021
Q4 | $6.25M | Buy |
460,151
+12,936
| +3% | +$176K | 0.01% | 600 |
|
2021
Q3 | $9.37M | Sell |
447,215
-33,954
| -7% | -$712K | 0.02% | 447 |
|
2021
Q2 | $11.5M | Buy |
481,169
+30,000
| +7% | +$719K | 0.02% | 404 |
|
2021
Q1 | $13.2M | Buy |
451,169
+237,278
| +111% | +$6.95M | 0.03% | 370 |
|
2020
Q4 | $6.39M | Buy |
+213,891
| New | +$6.39M | 0.01% | 531 |
|